Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NeuroSthlm011 AB
AB
Active
Org 5591698450
Dartanjangs Gata 68, 168 70
Bromma
Medical specialists activities
·
NACE 8622
Est. 2018 · 7 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
NeuroSthlm011 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
218
226
270
269
335
Staff expenses
−13
−4
−0
−10
—
EBITDA
146
144
218
179
227
Depreciation & amort.
—
—
—
—
−0
EBIT
146
144
218
179
227
Net financials
0
0
0
−0
—
Profit before tax
146
144
219
179
227
Tax
−32
−31
−47
−38
−48
Net profit
115
113
172
141
179
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
195
219
269
236
310
Equity
142
140
197
166
215
Long-term debt
—
—
—
—
0
Short-term debt
53
79
73
70
95
Total debt
53
79
73
70
95
Financial ratios
5-year trend
EBITDA margin
66,9 %
This company
15,8 %
Market median
This company
Market median
323% above market
2021
2025
Equity ratio
72,7 %
This company
38,2 %
Market median
This company
Market median
90% above market
2021
2025
Return on equity
80,8 %
This company
18,4 %
Market median
This company
Market median
339% above market
2021
2025
Net profit margin
52,6 %
This company
8,1 %
Market median
This company
Market median
549% above market
2021
2025
Asset turnover
1,12×
This company
1,12×
Market median
This company
Market median
0% above market
2021
2025
Debt / equity
0,37×
This company
0,62×
Market median
This company
Market median
40% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on NeuroSthlm011 AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
